The demonstration that T4 – including the agarose-T4 formulation – was a proliferative factor for certain human tumor (breast, thyroid cancer) (42, 54) and animal cells (C6, F98, GL261 glioma cell lines) (43) was accompanied by evidence that unmodified tetrac inhibited the T4 effect. Here, CD4 is linked to central nervous system cancer.